Wenwei Xie
China Pharmaceutical University(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Bone Metabolism and Diseases, Mast cells and histamine, Quinazolinone synthesis and applications, Bone Tissue Engineering Materials
Most-Cited Works
- → Rational Design of Highly Selective Spleen Tyrosine Kinase Inhibitors(2012)47 cited
- → Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors(2013)39 cited
- → MiR-582-3p alleviates osteoarthritis progression by targeting YAP1(2020)23 cited
- → Down-regulation of FTX promotes the differentiation of osteoclasts in osteoporosis through the Notch1 signaling pathway by targeting miR-137(2020)15 cited
- → MiR-137 promotes TLR4/NF-κB pathway activity through targeting KDM4A, inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells and aggravates osteoporosis(2023)5 cited
- → A bone substitute composed of polymethyl-methacrylate bone cement and Bio-Gene allogeneic bone promotes osteoblast viability, adhesion and differentiation(2021)5 cited
- → [Biomechanical study of polymethyl methacrylate bone cement and allogeneic bone for strengthening sheep vertebrae].(2021)2 cited
- → Integrated transcriptomic analysis identifies lactylation-linked gemcitabine resistance and therapeutic targets in intrahepatic cholangiocarcinoma(2025)1 cited
- → Comparison of hip arthroplasty and internal fixation for the treatment of intertrochanteric fractures(2008)
- → The novel endogenous micropeptide XLH-36 binds Gemin4 to promote triple-negative breast cancer metastasis(2025)